Hyrimoz
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Hyrimoz, covering 2025-12-11 to 2026-01-12. Get the full timeline:
Most recent: Clinical Trial Update: Observational Study, to Assess Treatment Retention of an Adalimumab Biosimilar (Hyrimoz®) in IBD Patients in Real Life Setting